GO
Loading...

Enter multiple symbols separated by commas

Health Care Equipment and Supplies

More

  • TEL AVIV, July 27- Teva Pharmaceutical Industries has agreed to buy Allergan Plc's generic drugs business for $40.5 billion in a cash and stock deal that will turn the Israeli company into one of the world's largest pharmaceutical firms. It also will allow Dublin- based Allergan, the third-largest generic drugmaker in the United States, to focus on branded drugs...

  • UPDATE 1-Bellerophon's heart device fails study Monday, 27 Jul 2015 | 7:31 AM ET

    July 27- Bellerophon Therapeutics Inc said its implantable heart device failed to prevent heart failure in patients in a large study, casting doubts over an approval for the device in Europe. The device, Bioabsorbable Cardiac Matrix, was licensed to Bellerophon by BioLineRx Ltd in 2009.. BioLineRx's U.S.-listed shares fell 18 percent to $1.76 in premarket...

  • Bellerophon's heart device fails study Monday, 27 Jul 2015 | 6:36 AM ET

    July 27- Bellerophon Therapeutics Inc said its implantable heart device failed to prevent heart failure in patients in a large study, casting doubts over an approval for the device in Europe. The device, Bioabsorbable Cardiac Matrix, was tested in 303 patients who had already suffered a heart attack. The device was licensed to Bellerophon by BioLineRx Ltd in...

  • TEL AVIV, July 27- Teva Pharmaceutical Industries has agreed to buy Allergan Plc's generic drugs business for $40.5 billion in a deal that will turn Teva into one of the top 10 pharmaceutical companies. Allergan's generic business is generally seen as a better fit than Teva's previous target Mylan because it will improve Teva's distribution channels and...

  • July 24- Xerox Corp barely managed to eke out a profit in the second quarter after the printer and copier maker took a charge related to a revamp of its business that provides administrative and care-management services to government healthcare programs. Xerox, whose shares were down 0.7 percent in premarket trading, said last week it would record a charge of...

  • GENEVA/ WASHINGTON, July 24- World Trade Organization members met in Geneva on Friday trying to finalise a deal to cut tariffs on $1 trillion of information technology products from video games to medical equipment. The United States said a deal had been struck, but WTO Director General Roberto Azevedo postponed a press conference at which he and the talks'...

  • Boston Scientific slips on mixed view for rest of 2015 Thursday, 23 Jul 2015 | 11:00 AM ET

    MARLBOROUGH, Mass.— Shares of Boston Scientific fell Thursday after the medical device maker reported solid results in the second quarter but gave a more mixed view for the rest of 2015.. Boston Scientific Corp. said sales of heart rhythm devices slumped compared to last year while sales of medical and surgical equipment improved. Boston Scientific now...

  • July 23- Boston Scientific Corp cut its full-year profit forecast for the second time in the face of rising litigation costs linked to problems with its implantable device used to treat feminine stress urinary incontinence. A Delaware jury last month ordered Boston Scientific to pay $100 million to a woman injured by the mesh, the largest-ever verdict...

  • Boston Scientific profit soars Thursday, 23 Jul 2015 | 7:10 AM ET

    July 23- Medical device maker Boston Scientific Corp, dogged by litigation expenses last year, reported a jump in quarterly profit. Net income attributable to the company rose to $102 million, or 8 cents per share, in the second quarter ended June 30, from $4 million, or break even on a per share basis, a year earlier. Revenue fell 1.6 pct to $1.84 billion.

  • *Offers $63.50/ share for Thoratec. *Thoratec's shares rise 10 pct; St. July 22- St. Jude Medical Inc agreed to buy smaller rival Thoratec Corp for about $3.4 billion, giving it more devices for patients with the highest risk of heart failure.

  • BUZZ-Thoratec Corp: St. Jude Medical to buy for $3.4 bln Wednesday, 22 Jul 2015 | 8:00 AM ET

    JUDE MEDICAL TO BUY FOR $3.4 BLN@** Heart device maker's shares up 9.3 pct at $62.94. **Bigger rival St. Jude Medical Inc agrees to buy Thoratec for $3.4 bln to expand heart failure device portfolio. **Thoratec shares closed up 18 pct Tuesday after Bloomberg report on St.

  • July 22- St. Jude Medical Inc agreed to buy smaller rival Thoratec Corp for about $3.4 billion to expand its portfolio of heart failure devices. Jude said on Wednesday it would offer $63.50 per Thoratec share, which represents a premium of about 10 percent to the stock's Tuesday close. Thoratec's shares closed up 18 percent on Tuesday after Bloomberg reported...

  • St. Jude Medical adds more heart devices in $3.4B buy Wednesday, 22 Jul 2015 | 7:35 AM ET

    NEW YORK— St. Jude Medical will spend $3.4 billion in cash to acquire Thoratec, further bulking up its array of devices that are used to treat heart conditions. Thoratec's key product is an implantable device that helps patients' hearts pump more blood. Thoratec Corp. will be required to pay a termination fee of about $30 million if it backs out of the deal during the...

  • Heart device maker St. Jude to buy Thoratec for $3.4 bln Wednesday, 22 Jul 2015 | 7:10 AM ET

    July 22- Heart device maker St. Jude Medical Inc said it would buy smaller rival Thoratec Corp for $3.4 billion. Jude said it would offer $63.50 per Thoratec share, which represents a premium of about 10 percent to the stock's Tuesday close. Thoratec shares closed up 18 percent on Tuesday after Bloomberg reported that St.

  • *Posts 2nd- qtr adj profit of $4.57/ shr vs est $3.98. Procedures that used Intuitive's flagship da Vinci system, which assists in minimally invasive gynecological and urological surgeries, rose 14 percent in the second quarter from a year earlier, the company said on Tuesday. Intuitive sold 118 da Vinci systems in the quarter, up from 96 a year earlier.

  • Procedures that used Intuitive's flagship da Vinci surgical system, which assists in minimally invasive gynecological and urological surgeries, rose 14 percent in the second quarter from a year earlier, the company said. The company also earns every time one of its da Vinci systems is used in surgery. Revenue from the company's instrument and accessory...

  • Intuitive Surgical posts 30 pct rise in profit Tuesday, 21 Jul 2015 | 4:18 PM ET

    July 21- Robotic surgical equipment maker Intuitive Surgical Inc posted a 30 percent jump in quarterly profit, helped by a rise in procedures in most of its markets. The company's net income rose to $134.5 million, or $3.56 per share, in the second quarter ended June 30, from $104 million, or $2.77 per share, a year earlier. On an adjusted basis, it earned $4.57 per share.

  • July 21- Heart device maker St. Jude Medical Inc is in talks to buy smaller rival Thoratec Corp, Bloomberg reported, citing sources familiar with the matter. No final deal has been agreed and Thoratec could also opt to seek a different buyer, the report said. Pleasanton, California- based Thoratec's stock rose 27 percent to a record high of $62.05 on the Nasdaq on...

  • July 21- Heart device maker St. Jude Medical Inc is in talks to buy smaller rival Thoratec Corp, Bloomberg reported, citing sources familiar with the matter. While the two companies are in discussions, no final deal has been agreed, and Thoratec could also opt to seek a different buyer, the report said. Pleasanton, California- based Thoratec's stock rose 27 percent to a...

  • July 10- Edwards Lifesciences Corp said it would buy privately held heart device maker CardiAQ Valve Technologies Inc for up to $400 million to expand its portfolio of less-invasive mitral valve replacement devices. The deal comes nearly two months after Edwards stopped enrolling patients for a study of its less-invasive mitral heart valve device, Fortis.